Earnings Call Summary | Nautilus Biotechnology(NAUT.US) Q1 2024 Earnings Conference

The following is a summary of the Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript:Financial Performance:Nautilus Biotechnology reported Q1 2024 total operating expenses of $21.6 m

Futu News03:40 · Conference Call

Nautilus Biotechnology Shares Are Trading Higher After the Company Reported Better-than-expected Q1 EPS Results.

Nautilus Biotechnology Shares Are Trading Higher After the Company Reported Better-than-expected Q1 EPS Results.

Benzinga00:03

Press Release: Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Nautilus Biotechnology Reports First Quarter 2024 Financial Results SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a sing

Dow JonesApr 30 20:00

Nautilus Biotechnology 1Q Loss/Shr 15c >NAUT

Nautilus Biotechnology 1Q Loss/Shr 15c >NAUT

Dow JonesApr 30 20:00

Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected

Yahoo FinanceApr 30 19:36

Nautilus Biotechnology's Cash, Cash Equivalents, And Investments Were $247.7M As Of March 31, 2024

Nautilus Biotechnology's Cash, Cash Equivalents, And Investments Were $247.7M As Of March 31, 2024

BenzingaApr 30 19:06